Literature DB >> 26691952

Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations.

Pilar Brito-Zerón1, Elke Theander2, Chiara Baldini3, Raphaèle Seror4,5, Soledad Retamozo1,6, Luca Quartuccio7, Hendrika Bootsma8, Simon J Bowman9, Thomas Dörner10, Jacques-Eric Gottenberg11, Xavier Mariette4,5, Stefano Bombardieri3, Salvatore de Vita7, Thomas Mandl2, Wan-Fai Ng12, Aike A Kruize13, Athanasios Tzioufas14, Claudio Vitali15, Jill Buyon16, Peter Izmirly16, Robert Fox17, Manuel Ramos-Casals1.   

Abstract

Sjögren's syndrome (SjS) is a systemic autoimmune disease that mainly affects the exocrine glands, leading to generalized mucosal dryness. However, primary SjS may initially present with non-sicca (systemic) manifestations. When these features appear before the onset of an overt sicca syndrome, we may talk of an underlying 'occult' SjS. The European League Against Rheumatism (EULAR) has promoted and supported an international collaborative study group (EULAR-SS Task Force) aimed at developing consensual recommendations to provide a homogeneous approach to the patient with primary SjS presenting with systemic involvement. This review summarizes the key factors that should be taken into account in the diagnostic approach in a patient with suspected SjS according to the main clinical patterns of presentation, and is especially focused on organ-specific systemic disease presentations, including a consensus set of recommendations in order to reach an early diagnosis. Close collaboration with the different specialties involved through a comprehensive multidisciplinary approach is essential in SjS patients presenting with systemic involvements.

Entities:  

Keywords:  ESSDAI; Sjögren syndrome; anti-Ro/SS-A antibodies; classification criteria; early diagnosis; focal lymphocytic sialadenitis; systemic activity

Mesh:

Year:  2015        PMID: 26691952     DOI: 10.1586/1744666X.2016.1109449

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  35 in total

Review 1.  The Diagnosis and Treatment of Sjögren's Syndrome.

Authors:  Ana-Luisa Stefanski; Christian Tomiak; Uwe Pleyer; Thomas Dietrich; Gerd Rüdiger Burmester; Thomas Dörner
Journal:  Dtsch Arztebl Int       Date:  2017-05-26       Impact factor: 5.594

Review 2.  Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.

Authors:  Pilar Brito-Zerón; Soledad Retamozo; Hoda Gheitasi; Manuel Ramos-Casals
Journal:  Drugs       Date:  2016-11       Impact factor: 9.546

3.  Transcultural adaptation of the EULAR activity index for primary Sjogren's syndrome in Argentine.

Authors:  Anastasia Secco; Lucila Marino; Natalia Herscovich; Pedro Aicardi; Lorena Techera; Lorena Takashima; María Lida Santiago; Felix Romanini; Marta Mamani; Antonio C Catalán Pellet
Journal:  Eur J Rheumatol       Date:  2019-12-16

4.  Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.

Authors:  J Demarchi; S Papasidero; M A Medina; D Klajn; R Chaparro Del Moral; O Rillo; V Martiré; G Crespo; A Secco; A Catalan Pellet; C Amitrano; C Crow; C Asnal; P Pucci; F Caeiro; N Benzanquen; J P Pirola; M Mayer; F Zazzetti; S Velez; J Barreira; N Tamborenea; L Santiago; L Raiti
Journal:  Clin Rheumatol       Date:  2017-09-14       Impact factor: 2.980

5.  Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement.

Authors:  Andreina Manfredi; Marco Sebastiani; Stefania Cerri; Giulia Cassone; Pietrantonio Bellini; Giovanni Della Casa; Fabrizio Luppi; Clodoveo Ferri
Journal:  Clin Rheumatol       Date:  2017-03-21       Impact factor: 2.980

Review 6.  Innate immunity in Sjögren's syndrome.

Authors:  Jeremy Kiripolsky; Liam G McCabe; Jill M Kramer
Journal:  Clin Immunol       Date:  2017-04-08       Impact factor: 3.969

7.  Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal).

Authors:  Virginia Fernandes Moça Trevisani; Alisson Pugliesi; Sandra Gofinet Pasoto; Maria Lucia Lemos Lopes; Lissiane Karine Noronha Guedes; Samira Tatiyama Miyamoto; Marilena Leal Mesquita Silvestre Fernandes; Sonia Cristina de Magalhães Souza Fialho; Aysa César Pinheiro; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lúcia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Nayara Libório-Kimura; Maria Carmen Lopes Ferreira Silva Santos; Diego Ustárroz Cantali; Juliana D'Agostino Gennari; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; César Ramos Rocha-Filho; Fabiola Reis Oliveira; Aline Pereira da Rocha; Valeria Valim
Journal:  Adv Rheumatol       Date:  2022-06-01

8.  Decreased microRNA-181a and -16 expression levels in the labial salivary glands of Sjögren syndrome patients.

Authors:  Yuhua Wang; Guohua Zhang; Lingling Zhang; Miansong Zhao; Hongdong Huang
Journal:  Exp Ther Med       Date:  2017-10-31       Impact factor: 2.447

9.  Upregulated Chemokine and Rho-GTPase Genes Define Immune Cell Emigration into Salivary Glands of Sjögren's Syndrome-Susceptible C57BL/6.NOD-Aec1Aec2 Mice.

Authors:  Ammon B Peck; Cuong Q Nguyen; Julian L Ambrus
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

10.  Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjögren's Syndrome.

Authors:  Matteo Di Marino; Paola Conigliaro; Francesco Aiello; Claudia Valeri; Clarissa Giannini; Raffaele Mancino; Stella Modica; Carlo Nucci; Roberto Perricone; Massimo Cesareo
Journal:  J Ophthalmol       Date:  2021-06-10       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.